Chemical Namenifurtimox
Dosage FormTablets (oral; 30mg, 120mg)
Drug ClassAntiprotozoal
SystemBlood, Digestive, Cardiovascular, Nervous
CompanyBayer HealthCare Pharmaceuticals Inc.
Approval Year2020


  • Indicated in pediatric patients (birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease (American Trypanosomiasis) caused by Trypanosoma cruzi
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Lampit (nifurtimox) Prescribing Information. 2020Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ